InDex Pharmaceuticals: Initial take on financing terms

Research Note

2021-01-14

10:42

Redeye leaves its initial view on the terms of the rights issue.

FE

Filip Einarsson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.